Related Experiment Video

Updated: Jun 3, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism is associated with increased risk of osteosarcoma

Wen Wang1, Jian Wang, Haihan Song

  • 1Traumatic Orthopedic Department, General Hospital of Jinan Military Command, Jinan, PR China.

Genetic Testing and Molecular Biomarkers
|April 2, 2011
PubMed
Abstract

Insights

The Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene +49G/A polymorphism is linked to a higher risk of osteosarcoma in the Chinese population. This finding suggests CTLA-4 variants may influence cancer susceptibility.

Area of Science:

  • Immunogenetics
  • Oncology
  • Molecular Biology

Background:

  • Cytotoxic T-lymphocyte antigen-4 (CTLA-4) is a key regulator of T-cell activation, crucial in immune responses against tumors.
  • The CTLA-4 gene +49G/A polymorphism (rs231775) has been implicated in the development of various cancers.

Purpose of the Study:

  • To examine the association between the CTLA-4 gene +49G/A polymorphism and osteosarcoma risk.
  • Focus on the Chinese population to understand genetic predisposition to this bone cancer.

Main Methods:

  • Genotyping of the CTLA-4 +49G/A variant using polymerase chain reaction-restriction fragment length polymorphism.
  • Comparison of genotype and allele frequencies between 205 osteosarcoma patients and 216 healthy controls.
  • Statistical analysis employed the Chi-square test to evaluate associations.

Main Results:

  • The CTLA-4 +49AA genotype was significantly more frequent in osteosarcoma patients (OR 2.27, p=0.010).
  • The +49A allele also showed increased frequency in the patient group (OR 1.41, p=0.015).
  • These findings indicate a genetic link between this CTLA-4 polymorphism and osteosarcoma.

Conclusions:

  • The +49G/A polymorphism in the CTLA-4 gene is associated with an elevated susceptibility to osteosarcoma.
  • This genetic variation may play a role in the pathogenesis of osteosarcoma in the studied population.

More Related Videos

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...